1. Home
  2. NVAX vs PGNY Comparison

NVAX vs PGNY Comparison

Compare NVAX & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

SELL

Current Price

$8.05

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Logo Progyny Inc.

PGNY

Progyny Inc.

SELL

Current Price

$37.15

Market Cap

2.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NVAX
PGNY
Founded
1987
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Misc Health and Biotechnology Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.2B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
NVAX
PGNY
Price
$8.05
$37.15
Analyst Decision
Buy
Strong Buy
Analyst Count
9
12
Target Price
$14.11
★ $37.25
AVG Volume (30 Days)
★ 5.8M
972.3K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 309.76
N/A
EPS
N/A
★ 0.95
Revenue
$1,123,479,000.00
★ $1,288,661,000.00
Revenue This Year
N/A
$6.82
Revenue Next Year
N/A
$11.43
P/E Ratio
★ N/A
$38.24
Revenue Growth
★ 64.69
N/A
52 Week Low
$6.20
$16.10
52 Week High
$13.39
$37.16

Technical Indicators

Market Signals
Indicator
NVAX
PGNY
Relative Strength Index (RSI) 34.94 83.18
Support Level $7.48 $24.89
Resistance Level $10.64 N/A
Average True Range (ATR) 0.71 1.16
MACD -0.23 0.61
Stochastic Oscillator 1.09 99.53

Price Performance

Historical Comparison
NVAX
PGNY

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

About PGNY Progyny Inc.

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

Share on Social Networks: